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Abstract
Background: Gulf War Illness (GWI) remains a serious health consequence for at least 11,000 veterans of the first Gulf War
in the early 1990s. Our understanding of the health consequences that resulted remains inadequate, and this is of great concern
with another deployment to the same theater of operations occurring now. Chronic immune cell dysfunction and activation
have been demonstrated in patients with GWI, although the literature is not uniform. We exposed GWI patients and matched
controls to an exercise challenge to explore differences in immune cell function measured by classic immune assays and gene
expression profiling.
Methods: This pilot study enrolled 9 GWI cases identified from the Department of Veterans Affairs GWI registry, and 11
sedentary control veterans who had not been deployed to the Persian Gulf and were matched to cases by sex, body mass index
(BMI) and age. We measured peripheral blood cell numbers, NK cytotoxicity, cytokines and expression levels of 20,000 genes
immediately before, immediately after and 4 hours following a standard bicycle ergometer exercise challenge.
Results: A repeated-measures analysis of variance revealed statistically significant differences for three NK cell subsets and NK
cytotoxicity between cases and controls (p < 0.05). Linear regression analysis correlating NK cell numbers to the gene
expression profiles showed high correlation of genes associated with NK cell function, serving as a biologic validation of both
the in vitro assays and the microarray platform. Intracellular perforin levels in NK and CD8 T-cells trended lower and showed a
flatter profile in GWI cases than controls, as did the expression levels of the perforin gene PRF1. Genes distinguishing cases
from controls were associated with the glucocorticoid signaling pathway.
Conclusion: GWI patients demonstrated impaired immune function as demonstrated by decreased NK cytotoxicity and
altered gene expression associated with NK cell function. Pro-inflammatory cytokines, T-cell ratios, and dysregulated mediators
of the stress response (including salivary cortisol) were also altered in GWI cases compared to control subjects. An interesting
and potentially important observation was that the exercise challenge augments these differences, with the most significant
effects observed immediately after the stressor, possibly implicating some block in the NK and CD8 T-cells ability to respond
to "stress-mediated activation". This has positive implications for the development of laboratory diagnostic tests for this
syndrome and provides a paradigm for exploration of the immuno-physiological mechanisms that are operating in GWI, and
similar complex syndromes. Our results do not necessarily elucidate the cause of GWI, but they do reveal a role for immune
cell dysfunction in sustaining illness.
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Background
Some veterans returning from the first Persian Gulf War,
Operations Desert Shield and Desert Storm (1990–1991),
reported a variety of symptoms including fatigue, muscu-
loskeletal discomfort, skin rashes, and cognitive dysfunc-
tion [1-3]. Because many of these veterans potentially
experienced various hazards such as physical and psycho-
logical stressors, multiple vaccinations, prophylactic med-
ications, infectious agents, pesticides, depleted uranium,
oil well fires and smoke, and chemical and biological war-
fare agents, many hypotheses as to the cause of the syn-
drome, now called Gulf War Illness (GWI), have ensued
[4]. As yet there are no diagnostic clinical signs or labora-
tory abnormalities that distinguish GWI and the patho-
physiology remains inchoate. Thus, there is no specific
pharmacological treatment and many of the veterans
affected continue to be unwell some 18 years after their
return from combat. Perhaps more important, the current
deployment of larger numbers of military personnel back
to this region, for considerably longer tours of duty, will
likely cause considerable morbidity through GWI and
similar poorly explained illnesses. Now it is even more
important that additional studies are pursued to further
our understanding of the illness in order that better treat-
ments are developed. To date, the effects of the numerous
different exposures on the veterans are still unclear, but it
is likely that many would result in immune function alter-
ations. These have been demonstrated in GWI by several
groups [5-7], although the results have not been uniform.
We hypothesize that there is a possible heterogeneity to
GWI similar to that seen in Chronic Fatigue Syndrome
(CFS), and the functional impairment oscillates over the
many years of the illness. This makes it difficult to identify
the biochemical and physiological measures that are dis-
turbed, as it changes with the symptoms experienced.
Along with this, GWI veterans exhibit a post-exertional
fatigue that exacerbates clinical symptoms such as pain
and cognitive impairment. In an attempt to measure the
changing functionality within subjects, we used an exer-
cise challenge paradigm. We believe this would amplify
the immune cell dysfunction, allowing us to monitor pos-
sible differences in physiologic responsiveness between
Gulf war veterans with and without multi-symptom ill-
ness. The biological responsiveness was measured using
both conventional immunological assays as in the previ-
ously published literature, and whole genome expression
profiling, in an attempt to understand the pathophysiol-
ogy of the illness in terms of the complex biological net-
works.
Methods
This study was reviewed and approved by Miami Univer-
sity, Department of Veterans Affairs, and Centers for Dis-
ease Control and Prevention Institutional Review Boards.
All participants were volunteers who gave informed con-
sent.
In this paper we report on a total of 20 subjects (9 GWI
and 11 control subjects) taken from a larger study, in an
attempt to determine the effectiveness of our approach in
evaluating the significant biological differences between
GWI cases and controls. Demographic data is summarized
in Table 1.
Subjects
The GWI cases, between the ages of 30 and 55 years old,
were identified from the Department of Veterans Affairs'
Gulf War Registry, who had no current medical or psychi-
atric conditions that could preclude GWI as the primary
explanation for their fatiguing illness. We also excluded
individuals taking medications that could impact
immune function (e.g. steroids, immunosuppressive
drugs). All cases were veterans deployed to the theater of
operations between August 8, 1990 and July 31, 1991
who met the 1998 GWI illness criteria utilized by CDC
and the Department of Veterans Affairs [2]. This includes
at least one chronic symptom (present longer than 6
months) of fatigue or mood or cognitive complaints and
chronic joint pain or stiffness or muscle pain.
As a comparison group we enrolled 11 well veteran con-
trols from the local National Guard units, who defined
Table 1: Demographic and physiological parameters of subjects involved in the exercise challenge paradigm.
Demographic data Controls GWI
Number of subjects 11 9
Race African American 4 2
Hispanic 4 6
White 3 1
Mean Age (years) (Range) 43.8 (33 – 52) 42.8 (34 – 51)
Mean BMI (kg/m2) (Range) 26.7 (18.8 – 31.0) 29.1 (24.2 – 31.5)
Mean Peak VO2 max
1 (ml/kg/min) (± SE) 28.05 (± 1.59) 25.05 (± 0.72)
Mean % Predicted (ml/kg/min) (± SE) 78.36 (± 3.41)* 67.8 (± 1.75)*
* Statistical difference measured by a Student t-Test with equal variance p = 0.015
1 Peak VO2 max is the increase in "maximal" oxygen uptake measured during an incremental maximal exercise protocol.BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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themselves as sedentary and were of the same age, sex and
BMI as the GWI cases (Table 1).
Exercise challenge
The exercise challenge was performed in the morning, to
avoid inter-subject differences in variables measured due
to diurnal variation. Subjects arrived at the clinic prior to
breakfast, had an intravenous line placement, were served
breakfast (contents uniform for all subjects), and lay
down for 30 minutes prior to the initial blood draw (T0).
Following this, they participated in symptom-limited
maximum graded exercise stress test on a bicycle ergom-
eter [8]. This involved pedaling at a power output of 60
watts for 2 minutes and increasing this every 2 minutes, by
30 watts until one of the maximal test criteria were met.
These were a plateau in maximal oxygen consumption, a
respiratory exchange ratio greater than 1.15 or the subject
stopped the test despite vocal urging from the staff All
exercise tests were conducted in compliance with the
American College of Sports Medicine's published guide-
lines [9]. We collected a second blood sample (T1) imme-
diately following the challenge (approximately 30
minutes from the start). Subjects then rested for 3 hours
following which we obtained a third (T2) blood speci-
men. There were no adverse events observed as a conse-
quence of the exercise challenge in this study
Cytokine studies
We measured TNFα, IL10, IL6, IL5, IFNγ, and IL1α using
heparanized whole blood collected at each time point. To
measure in vitro cytokine production we cultured cells for
48 hours at 37°C in 5% CO2, either unstimulated or stim-
ulated with phytohemagglutinin (PHA) following which
supernatants were collected and frozen at -70°C until ana-
lyzed using the Immunotech enzyme-linked immu-
noassay (ELISA) kits (Beckman Coulter, Hialeah, FL). We
also measured in vivo plasma TNFα, IL10 and IL6 with a
high sensitivity ELISA assay (sensitivity: TNFα – 0.13 pg/
ml; IL10 – 0.05 pg/ml; IL6 – 0.02 pg/ml; vendor – Bender
MedSystems, Burlingame, CA).
Salivary cortisol
All subjects submitted 5 saliva samples collected into
Salivette tubes (Sarstedt, Germany). Samples were col-
lected at 18:00, the evening prior to the exercise challenge
(T-12), at 06:00 (T-2) on the morning of the assessments
and exercise challenge, along with blood samples imme-
diately before the morning exercise test (T0), within 5 min
of completion of the test (T1) and at 16:00 (T2). Salivary
cortisol was measured by a high sensitivity ELISA assay
(sensitivity – < .003 μg/dL; vendor – Salimetrics LLC, State
College, PA). Assays were run using the Biomek 2000
robotic system with high and low concentrations of corti-
sol control samples being included in each assay. For this
assay, the morning range for healthy adults was 0.940 –
1.551 μg/dL, and the afternoon range, undetectable to
0.359 μg/dl.
Cell surface phenotyping by flow cytometry
Ethylenediamine tetra-acetic acid anti-coagulated whole
blood was surface-stained with optimal dilutions for
CD19, CD3, CD4, CD8, CD56, CD16, and CD11a, with
isotype controls in four color combinations for 15 min at
25°C. Samples were then fixed and lysed with Optilyse-C
reagent, followed by analysis on a FC500 flow cytometer.
All reagents and instrumentation were from the Beckman
Coulter Corporation (Hialeah, FL). The accuracy and pre-
cision of analyses were optimized through the adherence
to the CDC's recommendations for flow cytometric anal-
yses [10].
Flow cytometric assessment of intracellular perforin
The flow cytometric method used for the semi-quantita-
tive assessment of intracellular perforin is published [11].
NK cell activity
The cytolytic activity of the whole blood was measured
against a tumor cell target (K562 cells labeled with 51Cr),
and relates the number of cells in the sample that are phe-
notypically NK cells. The assay was performed as
described by Maher et al. [12].
Gene expression profiling
Blood was collected into an 8 ml cell preparation tube
((CPT); Becton, Dickinson and Company, Franklin Lakes,
NJ) containing sodium citrate at T0 (baseline), T1 (imme-
diately after stressor) and T2 (3 hour recovery). The CPT
was processed at the collection site according to the man-
ufacturer's instructions and peripheral blood mononu-
clear cells (PBMCs) cryopreserved at 5 × 106 cells/ml
freeze medium. Prior to shipping of specimens to the
CDC, a 2 ml aliquot of each sample was spun down and
the cell pellet resuspended in 1 ml TRIzol reagent. At the
CDC laboratories RNA was extracted according to manu-
facturer's instructions and the RNA quality and quantity
assessed using the Agilent 2100 Bioanalyzer. Two μg of
total RNA was labeled using the One-Cycle Target Labe-
ling Assay (Affymetrix, Santa Clara, CA, USA) including
amplification and labeling controls from the GeneChip®
Eukaryotic Poly-A RNA Control Kit. All methodologies
followed those suggested by the manufacturer. The frag-
mented antisense biotin-labeled cRNA had hybridization
buffer, Eukaryotic Hybridization Controls (to confirm the
sensitivity of hybridization), and OligoB2 controls (posi-
tive controls used to orient and grid the array) were added
just prior to hybridization to the Affymetrix Human U133
plus 2.0 chips. Hybridization was at 45°C for 16 hours as
described in the Affymetrix Users manual [13], followed
by washing and staining of arrays with the phycoerythrin-
strepavidin conjugate performed using the GeneChip Flu-BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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idics Station with the EukGE-WS2v5_450 protocol. Chips
were scanned using the Affymetrix GeneChip Scanner
3000 and the Affymetrix GeneChip® Operating Software
(GCOS) was utilized for the management, sharing and
initial processing of the expression data. Array quality
control was performed using the Expression Console™
software (version 1.1, Affymetrix).
The array data files have been deposited in ArrayExpress
http://www.ebi.ac.uk/arrayexpress. Accession number: E-
MEXP-2069.
Data analysis
Statistical analysis of immune screening data
To investigate the relationship between immune markers
and the case/control groups, multivariate analysis of data
from T0 to T1 and T2 time points was performed using
repeated-measures analysis of variance ((ANOVA), gen-
eral linear models procedure). For all the statistical tests
applied, 2-tailed p < 0.05 was considered to be statistically
significant. SAS statistical software (version 9.1; SAS Insti-
tute) was used to conduct the analyses.
Gene expression data analysis
The CEL files for each array were imported into BRB Array-
Tools (v3.6.0), developed by Dr. Richard Simon and Amy
Peng Lam at the National Cancer Institute and Emmes
Corporation http://linus.nci.nih.gov/BRB-Array
Tools.html. Data was normalized using the robust multi-
chip average (RMA) algorithm and a logarithmic (base 2)
transformation was applied to the signal intensities. Probe
sets showing minimal variation across the arrays were
excluded from the analysis, those whose expression dif-
fered by at least 1.5 fold from the median in at least 20%
of the arrays were retained, giving 9,140 probe sets for fur-
ther analysis. The Quantitative Trait Analysis (QTA) tool
was used to identify genes whose expression was signifi-
cantly related to the cell numbers of the different lym-
phocyte subsets. We computed a statistical significance
level for each gene testing the hypothesis that the Spear-
man's correlation between gene expression and each vari-
able was zero. These p- values were then used in a
multivariate permutation test [14,15] in which the cell
numbers were randomly permuted among the arrays. We
used the multivariate permutation test to provide 90%
confidence that the false discovery rate (FDR) was < 10%.
The FDR is the proportion of false positives in the list of
genes claimed to be differentially expressed. The multivar-
iate permutation test is non-parametric and does not
require the assumption of Gaussian distributions.
Biological interpretation of the results was achieved using
the DAVID Knowledgebase http://david.abcc.ncifcrf.gov/
[16,17] for functional annotation and enrichment analy-
sis. The threshold of the EASE score was set at 0.1 (a mod-
ified Fisher Exact p-value, where perfect enrichment = 0),
with a minimum requirement of 5 genes present in the
group. Ingenuity Pathway Analysis (IPA, Ingenuity® Sys-
tems; Mountain View, CA. http://www.ingenuity.com)
was used for network analysis of gene lists.
Quantitative real-time polymerase chain reaction (qPCR)
Validation of the microarray gene expression findings was
performed on all subjects with enough RNA at each time
point (3 controls and 3 GWI cases) using qPCR. Eleven
genes were validated that were of particular physiological
significance, either differentiating GWI cases from con-
trols at T1 (hierarchical clustering data) or that showed
up- and down-regulation between time points. The genes
are enumerated in additional file 1. Endogenous control
genes are required to account for the amount of input
RNA, and they need to be equally expressed across illness
class and time points. Ten genes were chosen on the basis
of the microarray gene expression data that showed low
coefficients of variation across all arrays, and also had dif-
ferent biological functions to avoid co-regulated genes.
GeNorm [18] was used to select the most stable pair-wise
combination of reference genes, which were PGK1 and
GAPDH.
Information on all primers and probe sets used in this val-
idation are given in additional file 1[19]. For each set PCR
amplification efficiency (E = 10-1/slope) was determined
using a 5-step 5 fold dilution standard curve (25 ng to 4
pg) and pooled PBMC total RNA from several donors.
One microgram of RNA was reverse transcribed into
cDNA using random hexamers for the template cDNA.
qPCR was performed using the LightCycler® 480 system
(Roche Applied Science, Indianapolis, IN) in 96 well
plates with Taqman universal PCR master mix (Applied
Biosystems, Foster City, CA) according to the manufac-
turer's instructions using primers and probes outlined in
additional file 1. All samples, including the external
standards and non-template control were run in triplicate.
The 25 μL reaction volume contained 1× Taqman PCR
Master Mix, 0.8 μmol/L of each primer, and 2 μL template.
The cycling conditions consisted of one cycle at 95°C for
10 min followed by 40 cycles of 95°C × 15 s, 60°C × 15 s
and 72°C × 45 s. Data was analyzed using the Lightcycler®
480 software (version 1.50).
Initial optimization experiments of the primer-probe sets
showed that all PCR products were single bands by agar-
ose gel electrophoresis and that the calibration curves gen-
erated from PBMC total RNA (plotting relative
concentrations against the threshold cycle (Ct)) had RSq
values (an indicator of line fit) from 0.995 to 1.000 for all
primer pairs. Based on the slopes of the standard curves,
the amplification efficiencies ranged from 1.90 to 2.10.BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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Results
GWI cases and control subjects performed similarly dur-
ing the exercise challenge as shown by comparing their
VO2 max (ml/kg/min) values, which assesses their level of
physical fitness, using a Student t Test. No statistically sig-
nificant differences were found (Table 1). Therefore, the
biological differences that were measured in this study
were not related to exertional differences.
Statistical analysis of immune cell numbers and functional 
assay data
The changes in immune measures by illness class that
showed significant differences (p < 0.05) were NK cyto-
toxicity (at T0 and T1), CD3- CD56+, CD3- CD16+, and
CD3- CD16+ CD11a+ NK cell numbers (all at T2), as well
as the response to PHA-stimulation measured in the
supernatants of cultured lymphocytes for IL5 and IFNγ
(all times) (additional file 2). A significant interaction of
time and illness class was observed in CD3- CD56+ cell
counts, CD4/CD8 T-cell ratio, PHA-stimulation measures
for the Th2 cytokine IL5 and the proinflammatory
cytokine TNFα (Additional file 2). Significant time effects
(p < 0.001) were observed for all immune variables except
NK cytotoxicity, IL6 and IL10 plasma levels, and the in
vitro PHA cytokine stimulation measures.
The changes in cell subset numbers across time were not
as large in the GWI cases compared to controls (not statis-
tically significant (additional file 2)); however, for the
CD4/CD8 T-cell ratio, statistically significant differences
in illness class, time and the illness class × time interaction
were identified (additional file 2). Control subjects had
higher CD4/CD8 T-cell ratios at all time points compared
to cases, with decreases at T1 for both. This results from an
increase in the number of CD3+CD8+ lymphocytes
brought into circulation immediately after the stressor
(108% from baseline for controls) compared to CD3+
CD4+ (30%). This effect is less pronounced in GWI cases,
which show similar CD8 and CD4 T cell numbers to con-
trols at baseline with changes of 64% (p = 0.029) and
25% (p = 0.234) respectively, after the stressor.
Correlation analysis of gene expression data and immune 
cell numbers by QTA
The expression of 141 unique probe sets were identified as
being correlated to NK cell subset numbers (Spearman's
rank correlation coefficients > 0.43), with over 65% of
probe sets being common to all 3 subsets. The association
between these probe sets and NK cell function was sup-
ported by literature searches; of the 141 probe sets identi-
fied by QTA, 108 (77%) were strongly implicated in NK
cell function (additional file 3).
Examining the gene expression levels of the correlated
probe sets between T0-T1 for the control subjects, we
found 49 showed a 2-fold increase (additional file 4), and
none were decreased using the same criteria. Functional
annotation of these genes indicated signal transduction as
a predominating biological process, containing 19/49
(39%) of submitted probe sets. Fifteen genes were identi-
fied as receptors: CD247, EDG8, GPR56, IL2RB, KIR3DL2,
KIR3DL1, KIR2DL5A, KIR2DS5, KIR2DL2, KLRD1,
KLRF1, PTGDR, TRA, and TRD. Examining the expression
levels of the GWI subjects only 1 probe set (PTGDR)
showed a 2-fold increase in expression, and no probe sets
showed a decrease. Repeated measures ANOVA showed
that 132 probe sets were statistically significantly different
with respect to time, and 82 by illness class, with 74 com-
mon to both (additional file 4). No probe sets were signif-
icant in the interaction. Closer inspection showed some
genes, for example GFOD1, ZBTB16 and RNF165, were
statistically significantly different in both the time and ill-
ness class analysis (indicating different expression levels),
but showed comparable responses between time points
(similar fold changes). Other genes showed differences in
expression levels and were less responsive (smaller fold
changes) in the GWI cases compared to controls, such as
GZMB, CCL4 and FCG3A (alias CD16) (additional file 4).
In contrast probe sets identified in the QTA with B-cell
numbers showed no statistical significant differences in
the gene expression levels by illness class or time.
The genes that differentiated cases from controls in the NK
profiles were identified by hierarchical clustering of the
141 unique probe sets (average linkage and centered cor-
relation) using the time point immediately after the exer-
cise challenge (T1), when we expected differences to be
the largest. Figure 1 shows the heatmap of 11 probe sets
(9 unique genes) that clearly delineated GWI cases from
controls. To explore the biological connections between
these genes we used the Ingenuity Pathways Knowledge
Base and found 8/9 genes formed a single network (Figure
2).
Intracellular perforin levels
The intracellular perforin levels were measured by quanti-
tative flow cytometry in both NK and CD8+ cells, and the
combined data was then corrected to account for the
changes in cell numbers during the exercise challenge
(Figure 3). The repeated measures ANOVA showed that
there were no significant time or illness class effects in the
perforin levels (p-values = 0.0539 and 0.0921 respec-
tively), which probably reflects the high variance in the
measures and the small number of samples. The gene
expression (Figure 3) reflected the protein profiles, with
lower mRNA expression level in GWI cases compared to
controls.BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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Gene expression validation by real-time PCR
The exercise-related changes seen between the T0-T1 and
T1-T2 time points were very similar in 9/11 genes used in
the validation (additional file 5). Validation of the gene
expression data was seen in the lower expression levels for
GWI cases compared to controls at all time points in
KLRD1, GZMB, and PRF1, and at T1 for KLRC4 (addi-
tional file 6). The gene expression patterns of PIK3CA,
which showed an increase in expression in all 3 time
points in controls, and higher expression in GWI cases,
was validated by qPCR. (The data for the baseline time
point in the GWI cases were not available because of a
technical error). Four of 5 genes not part of the hierarchi-
cal clustering validated fully (additional file 5). The only
discordant result between the gene expression and qPCR
data was seen in GWI data for KLRC4  and  NCAM1
between the T2/T1 time points.
Discussion
The symptom spectrum of GWI is similar to CFS [20], and
our results mirror what is seen in the literature with regard
to CFS: chronic immune activation [21,22], low cytotoxic
immune function [23,24], and dysregulated mediators of
the stress response with low baseline salivary cortisol [25]
strongly reflecting the overlap between these two syn-
dromes. Decreased functional capacity of NK cells is the
one consistent finding in CFS studies [26] and Siegel et al.
[27] demonstrated that low NK cell function defined a
more severely ill cohort. In addition reduced NK cellular
cytotoxicity is associated with reduced intracellular per-
Heatmap depicting the expression levels of genes separating GWI cases from controls immediately after the exercise challenge Figure 1
Heatmap depicting the expression levels of genes separating GWI cases from controls immediately after the 
exercise challenge. Immediately after the exercise stress challenge is when we expected differences between GWI cases and 
controls to be maximal so the most likely time to find the most striking differences. Hierarchical clustering of the 141 probe 
sets correlating with NK cell subset numbers at the T1 time point was used to show that 9 genes were effective in separating 
cases from controls. High and low expression levels are shown as red and green respectively. Dendogram at the top shows the 
clustering results and gene names are given on the right side.BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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Functional network of the 9 NK genes differentiating cases from controls Figure 2
Functional network of the 9 NK genes differentiating cases from controls. The genes were overlaid onto a global 
molecular network developed from information contained in the Ingenuity Pathways Knowledge Base and networks were algo-
rithmically generated based on connectivity. The genes added to the network as connecting molecules are colored grey. The 
node shape denotes transmembrane receptor (vertical oval), transcription factor (horizontal oval), cytokine (square), kinase 
(triangle), peptidase (diamond), and a group or complex (double ringed circle). The edges stand for the gene relationship; solid 
lines indicate a direct interaction, a dashed line an indirect interaction. A solid arrow head between two nodes denotes gene A 
at arrow base "acts on" gene B at arrow head. Green node color indicates protein correlated to NK cell subset by QTA that 
differentiates GWI cases from controls.BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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Change in perforin levels during the exercise challenge time series adjusted for the number of NK and CD8+ cells Figure 3
Change in perforin levels during the exercise challenge time series adjusted for the number of NK and CD8+ 
cells. The top graph shows intracellular perforin molecules in both NK and CD8 T-cells and the bottom graph the gene 
expression data (mean signal intensity). Values are mean ± SD. Repeated measures ANOVA on the intracellular perforin levels 
showed time series differences bordering on the significant (p-value = 0.053), with illness class differences not significant (p-
value = 0.092).BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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forin [12]. In our study we showed significant group dif-
ferences in NK cytotoxicity, plus perforin levels that were
lower and showed a flatter profile in GWI cases than con-
trols (Figure 3) not reaching statistical significance proba-
bly due to small numbers and large variances. Gene
expression levels of perforin mRNA (PRF1) showed similar
profiles to the protein levels.
Lymphocytosis induced by exercise is well established in
the scientific literature [28,29] and results from the mobi-
lization of immunocompetent cells from immune organs
(lymph node and spleen) to the circulation. One to 2
hours into the exercise recovery period the lymphocyte
count decreases, sometimes to below pre-exercise levels
[30]. Our data confirmed reports that the NK cell subsets
are more sensitive to exercise stress than any other cell
subtypes [28], but for us it was important to differentiate
the causal effects of exercise alone, and to look for the dif-
ferences between GWI cases and the control subjects. Sta-
tistically significant differences were noted for the 3 NK
cell subsets between cases and controls, and a significant
interaction of illness class and time was observed in the
CD3- CD56+ subset. There were no statistically significant
differences in the VO2 max measures between cases and
controls (Table 1) therefore level of exercise performance
could not explain these changes. Correlating gene expres-
sion to particular cell subsets reflected the cellular shifts in
the peripheral blood cells with high statistical signifi-
cance. For example, 5 NK and T-cell specific surface mole-
cules (CD160, CD244, CD247, CD38 and CD56) [31]
were strongly correlated with the NK subset cell numbers
by QTA. To confirm that the gene expression changes
between cases and controls evident in our study were not
only due to the change in cell numbers, significant expres-
sion values were re-evaluated relative to cell numbers. In
summary our findings demonstrate control subjects had
greater numbers of genes showing expression changes
between the T0 and T1 (baseline-stress time points) than
GWI cases, and that expression levels in NK cells were con-
sistently lower in GWI cases. However, gene responsive-
ness varied. Some genes showed a similar responsiveness
to the stressor for both GWI cases and controls, whereas
others appeared less responsive to the stressor in the cases
(additional file 4). The differences in expression levels
were greatest at T1 (even when cell number differences
were accounted for) but were also present at T0 and T2,
when cell numbers were similar. The hierarchical cluster-
ing of the NK correlated genes showed that 9 separated
GWI cases from controls (Figure 1), each one associated
with NK cytotoxicity. All these genes play a role in major
cellular functions such as proliferation, activation and
apoptosis and the functional network established for 8 of
the 9 genes (Figure 2) reveals that 5 of the networked
genes (AP1, CD3, CD247, NFATC2 and PIK3CA) are part
of the glucorticoid receptor signaling pathway. Enhanced
negative-feedback sensitivity to glucorticoids is often seen
in CFS [32,33], as well as a blunted adrenocorticotropin
response to stressors [34], and hypocorticolism [35]. This
supports the hypothesis that hypo-function of the
hypothalamic pituitary adrenal (HPA) axis plays a role in
CFS, and probably in GWI also. Disturbances of the HPA
axis can be considered as a pathway that links to the
immunological disturbances evidenced in CFS and GWI.
Differences in the NK cell receptor mRNAs (KLRD1,
KLRC4, and KLRK1) have been validated between cases
and controls (Additional file 2). We know that each NK
cell expresses several inhibitory (KIR) and activating
(KLR) receptors [36,37], and the balance between the sig-
nals triggered by their engagement determines their bio-
logical response. The interaction of inhibitory receptors
by their cognate ligands (mostly classical and non-classi-
cal MHC class I molecules) keeps NK cells inhibited, part
of the "missing-self hypothesis" [38]. It has been shown
that NK cells that lack inhibitory receptors for self MHC
class I molecules are hyporesponsive [39]. Several activat-
ing receptors (KLR) have been described, and it is not
completely understood how these receptors cooperate
with each other, or how they distribute at a clonal level on
different NK cells. The effect of down-regulation of recep-
tor mRNA as we see in GWI cases is not known, and how
this alters the receptor interactions with cognate ligands is
not well understood. This lack of knowledge stems from
the heterogeneity and redundancy in the activating recep-
tors which is a drawback to understanding their func-
tional importance in NK cell immunobiology. It will be
important to elucidate how these changes affect the cell
phenotype and how this moderates the functioning of
immune cells. The cytotoxic effector functions of NK cells
are mediated by 2 major mechanisms, perforin/granzyme
and death receptor induction of apoptosis [40]. In the dif-
ferent analyses performed for this paper, we see that each
one of these components is implicated as being different
between GWI and control subjects. In fact PRF1  and
GZMB, along with KLR complex receptors and FASLG are
shown to distinguish cases from controls in the hierarchi-
cal clustering, and perforin is implicated in the functional
assay measurements (Additional file 2). TNFα differences
are noted between GWI cases and controls in the respon-
siveness of the cultured PBMC to stimulation with PHA.
We postulate that the down-regulation of several of the
NK receptors in GWI cases could explain the impaired
functional response of some lymphocyte subpopulations,
as seen by lower gene expression levels in GWI cases of
several genes implicated in NK and T-cell biology. It
appears that the depressed responsiveness of these genes
impacts cell proliferation and activation functions, along
with cell signaling and cell survival (apoptosis).BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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The shift in immune system functioning towards a Th2
(or allergy) profile has been evidenced before in GWI and
CFS patients [22,41], as has the contrasting position [6].
Peakman  et al. [42] reviewed 6 studies that directly
addressed the Th2 bias of the immune response as an
explanation for GWI and concluded that the data did not
support the hypothesis. We found elevated IL-5, a Th2
cytokine, in the GWI cases as compared to controls (Addi-
tional file 2); however, the ratio of a Th1 cytokine (IFNγ)
to IL-5 was determined and found to show no statistical
differences in the repeated measures ANOVA. We found
significant differences in CD4/CD8 ratios between cases
and controls. The clinical consequences of these changes
remain relatively unknown. Data from previous studies
showed the ratio was significantly elevated in GWI
patients compared to controls [43], the reverse of what we
found here. So as with CFS, there are several conflicting
reports in the literature regarding immune function [26].
We examined salivary cortisol, a "stress hormone" at base-
line (T0), immediately after the exercise stress (T1) and 3
hours later (T2). Control subjects showed increased sali-
vary cortisol from T0 to T1 in our stress paradigm, whereas
it decreased in GWI cases. Several conditions are associ-
ated with changes in stress system activity [44,45] through
modulation of inflammatory responses and the Th1/Th2
balance they may suppress or potentiate disease activity
and/or progression. The differences seen here in stress
hormones may represent an important mechanism by
which stress affects immune-related disease susceptibility,
activity, and outcome.
This was a preliminary exploration to determine if an exer-
cise paradigm would help us in understanding the patho-
physiology of GWI and if whole genome expression
profiling would make a significant contribution to this
understanding. For this end we used a small subset of sub-
jects from a much larger study cohort, and two issues
arose. Firstly the matching of cases to controls by race fell
away (Table 1), and secondly, it was noted that the sub-
jects were brought into clinic in separate groups over a 16
month period, GWI veterans and then control subjects,
with little overlap. To address the first issue, we used a
multivariate ANOVA with multiple test correction on the
gene expression data to find the genes differing by race.
None of these were statistically significant in any of the
analyses presented in this paper. To manage the latter lim-
itation which would impact class comparison analyses,
we focused on differences across the time series. By using
within-person paired analysis we could examine exercise-
related changes and then compare the results of cases and
controls.
Conclusion
This study shows that exercise induces considerable phys-
iological change in the immune system and the changes
observed in GWI cases are less apparent than in control
subjects, with differences in the dynamics of the immune
response also obvious. Whether the gene expression
changes in response to exercise in the circulating immune
cells occur because of direct effects in the cells themselves,
or are a consequence of mobilizing cells with different
expression profiles from various depots is not fully known
[46]. It will be important to determine the confounding
effects of lymphocyte redistribution. The differences we
found are focused in the NK and T-cell populations,
involving signal transduction processes possibly through
differences in NK receptor expression. We have not eluci-
dated exactly what these changes are, but possible areas of
follow-up include the dynamic signaling interactions
between NK and T-cells with regard to proliferation, cell
cycle differences and activation. The question arises
whether the altered number of NK cells is a consequence
of the pathological status or a primary condition that
leads into the disease.
Another important question is what role do NK cells have
in maintaining immune homeostasis in disorders that are
thought to involve immune activation such as CFS and
GWI? The activities were not correlated with a particular
subset of NK cells, and further phenotypic and functional
analysis of the different subsets will be necessary to eluci-
date the immune cells involved in the pathophysiology of
GWI. Our data supports the idea of chronic immune cell
dysfunction, which appears to be centered on the NK and
T-cell lymphocyte populations. There are several plausible
explanations for the decrease in NK cell activity. It could
result from a shift in NK cell subsets resulting in a larger
population of cells with a lower activity profile, or possi-
bly changes in cytokine levels which modulate NK cell
activity or the presence of inhibitory substances which
could act as ligands binding to the KLR activation recep-
tors.
One of the most interesting and possibly useful observa-
tions in this study is that many of the baseline measures
show no statistical difference between GWI cases and con-
trol subjects. The most significant differences were
observed immediately after the exercise challenge, with
some of those differences being maintained as far out as 3
hours post-challenge. Thus the exercise challenge para-
digm should prove very useful in further elucidation of
the disease physiology. This also has positive implications
for the development of laboratory diagnostic tests for this
and other syndromes such as CFS. The interactions
between exercise stress and the immune system as viewed
by functional assays and gene expression profiling pro-
vide an excellent opportunity to explore the immuno-BMC Medical Genomics 2009, 2:12 http://www.biomedcentral.com/1755-8794/2/12
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physiological mechanisms that are operating in GWI, and
the possibility of extending this paradigm to other com-
plex syndromes.
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